Filing Details
- Accession Number:
- 0000899243-19-003383
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-02-12 21:41:59
- Reporting Period:
- 2018-12-12
- Accepted Time:
- 2019-02-12 21:41:59
- Original Submission Date:
- 2018-12-14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286199 | K Joseph Belanoff | C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-12 | 217,115 | $1.19 | 2,381,310 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-12 | 217,115 | $19.01 | 2,164,195 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-12-12 | 217,115 | $0.00 | 217,115 | $1.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 282,885 | 2019-03-26 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- Fully exercisable.
- The transactions described herein were originally reported on a Form 4 filed on December 14, 2018. This Form 4 is hereby being amended to correct the stock option exercise date and it does not describe any additional transactions.
Billionaire Hedge Funds
